CardioVascular BioTherapeutics, Inc. seeks to develop and commercialize novel and cost effective reqenerative therapies, diagnostic techniques and delivery methods for the treatment, early detection and prevention of cardiovascular diseases caused by lack of blood flow to tissues and organs.

HomePage_Image.jpg

Recent Press Releases

11/05/14 CVBT Update Press Release

09/16/14Annual Election Results

08/14/14
Court Ordered Annual Election - Rules of Conduct and Agenda

07/24/14
Delaware Appeal Voluntarily Dismissed


07/18/14
Notice of CVBT Court Ordered Meeting

07/07/14
Final Order Issued - Court Appoints Special Master for Annual
Elections.

05/30/14
Delaware Decision - Court Orders Annual Election


01/31/14
Delaware Appeal Regarding CVBT Board Stayed

01/08/14
Written Consent Update

11/27/13
CVBT Shareholders Again Vote for Change


11/19/13
Appeal Oral Argument Cancelled

11/16/13
CardioVascular BioTherapeutics, Inc., Stockholder Solicitation.

Media
January 2011
Investors.com: Small Drugmaker CVBT Claims Big Advance In Diabetes Wound Care

Readers_Digest_Press.gif


Image_BusinessWeek.gifline_vert.gifImage_PharmExec.gif

Upcoming Events:

CardioVascular BioTherapeutics, Inc.
Court Ordered Annual Shareholders Meeting
Date:August 18, 2014
Time:9:00am Pacific
Location:Suncoast Hotel and Casino in Las Vegas, NV

©2014 CardioVascular BioTherapeutics, Inc.